NATIONAL HARBOR, Md. (GenomeWeb) — In advance of its annual meeting held here this week, the Association for Molecular Pathology yesterday held a "corporate workshop day," during which clinical researchers shared user experiences and early data regarding a number of recently launched or in-development molecular diagnostic products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.